{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:29:06Z","timestamp":1791905346723,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK123293"],"award-info":[{"award-number":["R01DK123293"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2023.12.045","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T16:07:10Z","timestamp":1704384430000},"page":"221-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Recent advances in oral insulin delivery technologies"],"prefix":"10.1016","volume":"366","author":[{"given":"Ershuai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.045_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0010","first-page":"349","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure, nature reviews","volume":"16","author":"Eizirik","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.2.3286.1204","article-title":"Insulin in alcoholic solution by the mouth","volume":"2","author":"Harrison","year":"1923","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/14656566.4.7.1141","article-title":"Insulin analogues and other developments in insulin therapy for diabetes","volume":"4","author":"McAulay","year":"2003","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2213-8587(13)70006-8","article-title":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"1","author":"Kramer","year":"2013","journal-title":"The Lancet Diab. & Endocrinol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0035","series-title":"Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Individuals with Type 1 Diabetes: A Systematic Review and meta-Analysis","author":"Benkhadra","year":"2017"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.drudis.2018.11.010","article-title":"A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade","volume":"24","author":"Easa","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","article-title":"Advances in transdermal insulin delivery","volume":"139","author":"Zhang","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/193229681200600229","article-title":"Clinical use of U-500 regular insulin: review and meta-analysis","volume":"6","author":"Reutrakul","year":"2012","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0055","first-page":"947","article-title":"Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections, diabetes","volume":"8","author":"Riddlesworth","year":"2017","journal-title":"Therapy"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0060","first-page":"401","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?, diabetes","volume":"7","author":"Gentile","year":"2016","journal-title":"Therapy"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14341\/DM12095","article-title":"Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention","volume":"23","author":"Klimontov","year":"2020","journal-title":"Diab. Mellit."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0070","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dom.12501","article-title":"Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?","volume":"17","author":"Home","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0075","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/DDDT.S79322","article-title":"Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery","volume":"9","author":"Matteucci","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0080","first-page":"715","article-title":"One hundred years of insulin therapy, nature reviews","volume":"17","author":"Mathieu","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0085","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MJT.0000000000001097","article-title":"Insulin pump therapy","volume":"27","author":"Nimri","year":"2020","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0090","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00125-021-05413-7","article-title":"Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland","volume":"64","author":"Jeyam","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0095","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jocn.16071","article-title":"Local complications of insulin administration sites and effect on diabetes management","volume":"31","author":"Demir","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1932296819837972","article-title":"Tissue response to subcutaneous infusion catheter","volume":"14","author":"Zhang","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-023-01108-z","article-title":"An injectable and biodegradable zwitterionic gel for extending the longevity and performance of insulin infusion catheters","author":"Zhang","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1932296817691303","article-title":"Oral insulin delivery in a physiologic context","volume":"11","author":"Arbit","year":"2017","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40618-015-0326-3","article-title":"Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis","volume":"39","author":"Akbari","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1573399813666170621122742","article-title":"Oral insulin: myth or reality","volume":"14","author":"Kumar","year":"2018","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4155\/tde-2021-0021","article-title":"Oral insulin delivery: utopia, currently possible or a near reality?","volume":"12","author":"Pinelo","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/dom.14984","article-title":"Oral insulin: a history of ambition, failure and data torturing","volume":"25","author":"Heise","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0145","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.045","article-title":"Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery","volume":"342","author":"Xi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41551-019-0465-5","article-title":"Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability","volume":"4","author":"Lamson","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijbiomac.2020.02.079","article-title":"Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo","volume":"150","author":"Sudhakar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0165","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.1021\/acsami.0c04303","article-title":"A nanocomposite vehicle based on metal\u2013organic framework nanoparticle incorporated biodegradable microspheres for enhanced oral insulin delivery","volume":"12","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2021.11.020","article-title":"Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles","volume":"341","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2213-8587(18)30372-3","article-title":"Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial","volume":"7","author":"Halberg","year":"2019","journal-title":"The Lancet Diab. & Endocrinol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0180","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4155\/TDE.15.47","article-title":"Why most oral insulin formulations do not reach clinical trials","volume":"6","author":"Lopes","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0190","doi-asserted-by":"crossref","first-page":"1901935","DOI":"10.1002\/adma.201901935","article-title":"Oral delivery of biologics for precision medicine","volume":"32","author":"Dur\u00e1n-Lobato","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0200","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2020.04.006","article-title":"Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems","volume":"322","author":"Xu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0205","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/17425247.2014.917077","article-title":"Oral peptide and protein delivery: intestinal obstacles and commercial prospects","volume":"11","author":"Smart","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0210","first-page":"392","article-title":"Advances in oral peptide drug nanoparticles for diabetes mellitus treatment","volume":"15","author":"Li","year":"2022","journal-title":"Bioact. Mat."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0215","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0220","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/jacs.8b02089","article-title":"Acid-resistant mesoporous metal\u2013organic framework toward oral insulin delivery: protein encapsulation, protection, and release","volume":"140","author":"Chen","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0225","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly (\u03b3-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0230","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","volume":"33","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(96)01586-6","article-title":"The challenge of proteolytic enzymes in intestinal peptide delivery","volume":"46","author":"Langguth","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0240","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/mp500809f","article-title":"Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0245","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.progpolymsci.2012.04.004","article-title":"Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review","volume":"37","author":"Mukhopadhyay","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059524","article-title":"Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study","volume":"8","author":"Eldor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0255","series-title":"Multiple Oral Insulin (ORMD-0801) Doses Elicit a Cumulative Effect on Glucose Control in T2DM Patients","author":"Eldor","year":"2018"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2013.07.011","article-title":"Biotinylated liposomes as potential carriers for the oral delivery of insulin","volume":"10","author":"Zhang","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0265","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1039\/D0NR06104B","article-title":"Layer-by-layer coated nanoliposomes for oral delivery of insulin","volume":"13","author":"Zhang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2016.02.031","article-title":"Dextran-b-poly (lactide-co-glycolide) polymersome for oral delivery of insulin: in vitro and in vivo evaluation","volume":"227","author":"Alibolandi","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0275","doi-asserted-by":"crossref","first-page":"1910168","DOI":"10.1002\/adfm.201910168","article-title":"Liver-target and glucose-responsive Polymersomes toward mimicking endogenous insulin secretion with improved hepatic glucose utilization","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0280","doi-asserted-by":"crossref","first-page":"eabm4677","DOI":"10.1126\/sciadv.abm4677","article-title":"Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery\u2013understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejpb.2014.12.024","article-title":"Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles","volume":"97","author":"de Sousa","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2017.10.004","article-title":"Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier","volume":"124","author":"Menzel","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0305","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.1021\/acsami.7b16524","article-title":"Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery","volume":"10","author":"Wu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0310","doi-asserted-by":"crossref","first-page":"2109189","DOI":"10.1002\/adma.202109189","article-title":"Mucus penetrating and cell-binding Polyzwitterionic micelles as potent Oral nanomedicine for Cancer drug delivery","volume":"34","author":"Fan","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0315","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0320","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7150\/thno.61747","article-title":"Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0330","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007049","article-title":"Transepithelial transport of fc-targeted nanoparticles by the neonatal fc receptor for oral delivery","volume":"5","author":"Pridgen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0340","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12274-018-2264-9","article-title":"Glucose-responsive oral insulin delivery for postprandial glycemic regulation","volume":"12","author":"Yu","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0345","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.matt.2021.08.011","article-title":"Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes","volume":"4","author":"Xiao","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0350","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","article-title":"Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0355","first-page":"701","article-title":"Bile acids in glucose metabolism and insulin signalling\u2014mechanisms and research needs, nature reviews","volume":"15","author":"Ahmad","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-018-0481-z","article-title":"Marked differences in tight junction composition and macromolecular permeability among different intestinal cell types","volume":"16","author":"Pearce","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0365","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207829119","article-title":"The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery","volume":"119","author":"Lamson","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0370","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0375","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0380","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: a mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0385","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1039\/C9TB01081E","article-title":"Biomaterial\u2013tight junction interaction and potential impacts","volume":"7","author":"Han","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0390","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","article-title":"Target specific tight junction modulators","volume":"171","author":"Brunner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0395","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","article-title":"Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease","volume":"14","author":"Lerner","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0400","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/acs.chemrev.6b00562","article-title":"Biological activity of ionic liquids and their application in pharmaceutics and medicine","volume":"117","author":"Egorova","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0405","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2021.08.032","article-title":"Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients","volume":"338","author":"Wu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0410","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1039\/C3CC48650H","article-title":"Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility","volume":"50","author":"Williams","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0415","doi-asserted-by":"crossref","first-page":"2004819","DOI":"10.1002\/advs.202004819","article-title":"Recent advances in ionic liquids in biomedicine","volume":"8","author":"Curreri","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0420","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1039\/C6MD00358C","article-title":"Ionic liquids as a potential tool for drug delivery systems","volume":"7","author":"Adawiyah","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0425","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1073\/pnas.1403995111","article-title":"Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization","volume":"111","author":"Zakrewsky","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0430","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0435","doi-asserted-by":"crossref","first-page":"25298","DOI":"10.1039\/D1CP03349B","article-title":"The molecular mechanism behind the stabilization of insulin by choline and geranate (CAGE) ionic liquids\u2013computational insights into oral insulin drug formulation","volume":"23","author":"Palanisamy","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0440","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1021\/acsbiomaterials.0c01024","article-title":"Mucoadhesive Ionic Liquid Gel Patches for Oral Delivery","volume":"9","author":"Peng","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.07.012","article-title":"Micro and nanoscale technologies in oral drug delivery","volume":"157","author":"Ahadian","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0450","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00592-019-01403-9","article-title":"Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies","volume":"56","author":"Muntoni","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0455","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jfda.2017.02.001","article-title":"Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers","volume":"25","author":"Lin","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0460","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41551-021-00791-0","article-title":"Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin,","volume":"5","author":"Lee","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0465","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.1021\/acsami.1c00580","article-title":"Virus-mimicking mesoporous silica nanoparticles with an electrically neutral and hydrophilic surface to improve the oral absorption of insulin by breaking through dual barriers of the mucus layer and the intestinal epithelium","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0470","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1039\/C3PY01416A","article-title":"Oral glucose-and pH-sensitive nanocarriers for simulating insulin release in vivo","volume":"5","author":"Sun","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0475","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s11051-012-1219-4","article-title":"Concanavalin a conjugated biodegradable nanoparticles for oral insulin delivery","volume":"14","author":"Hurkat","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10837450.2020.1849282","article-title":"In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery","volume":"26","author":"Mutlu-Agardan","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0485","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/la051982u","article-title":"Gold nanoparticles as carriers for efficient transmucosal insulin delivery","volume":"22","author":"Joshi","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0490","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2021.08.005","article-title":"Nanocarriers for oral delivery of biologics: small carriers for big payloads","volume":"42","author":"Cao","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0495","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0500","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","article-title":"Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation","volume":"210","author":"Taverner","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41551-019-0513-1","article-title":"A new opening for orally taken peptide drugs,","volume":"4","author":"Artursson","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0510","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","article-title":"Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions","volume":"15","author":"Han","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0515","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1021\/acs.chemrev.2c00344","article-title":"Zwitterionic biomaterials","volume":"122","author":"Li","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0520","article-title":"Zwitterionic polymers: addressing the barriers for drug delivery","volume":"108177","author":"Li","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0525","series-title":"In Situ Polymerization of Zwitterions on Therapeutic Proteins to Enable their Effective Oral Delivery","first-page":"1128","volume":"17","author":"Fang","year":"2023"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0530","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1039\/D2BM01606K","article-title":"Crosslinked zwitterionic microcapsules to overcome gastrointestinal barriers for oral insulin delivery","volume":"11","author":"Ma","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0535","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2017.07.003","article-title":"Oral delivery of biologics using drug-device combinations","volume":"36","author":"Caffarel-Salvador","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0540","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s44222-022-00006-4","article-title":"Bioinspired oral delivery devices","volume":"1","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0545","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41591-019-0598-9","article-title":"A luminal unfolding microneedle injector for oral delivery of macromolecules","volume":"25","author":"Abramson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0550","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41591-019-0606-0","article-title":"Microneedle patch drug delivery in the gut","volume":"25","author":"Prausnitz","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0555","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.aau2277","article-title":"An ingestible self-orienting system for oral delivery of macromolecules","volume":"363","author":"Abramson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0565","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41587-021-01024-0","article-title":"Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors","volume":"40","author":"Abramson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0560","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.matt.2021.10.003","article-title":"Smart ingestible devices: orally delivering macromolecules and beyond","volume":"4","author":"Zhang","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0570","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.5134","article-title":"Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes","volume":"246","author":"Genser","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0575","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.12.045_bb0580","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1021\/acs.molpharmaceut.3c00482","article-title":"Oral drug delivery systems applied to launched products: value for the patients and industrial considerations","volume":"20","author":"Yoshida","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0585","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/dom.14901","article-title":"Oral insulin (ORMD-0801) in type 2 diabetes mellitus: a dose-finding 12-week randomized placebo-controlled study","volume":"25","author":"Eldor","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2023.12.045_bb0590","author":"Oramed Pharmaceuticals"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:31:40Z","timestamp":1738081900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923008295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":118,"alternative-id":["S0168365923008295"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.045","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in oral insulin delivery technologies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}